Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00969124 · ClinicalTrials.gov registry record · NA

Impact of Experience on Results With the Third Eye Retroscope

A NA study of Colorectal Neoplasms, sponsored by Avantis Medical Systems.

Completed
Registry status
NA
Development phase
328
Enrollment target
9
Study locations

NCT00969124: Completed NA study of Colorectal Neoplasms, sponsored by Avantis Medical Systems.

NCT00969124 is a NA study of Colorectal Neoplasms that has completed, run by Avantis Medical Systems. The registered enrollment target is 328 participants, below the 570-participant average among 54 other Colorectal Neoplasms trials with a reported enrollment target (42% lower). The trial reports 9 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00969124, a NA study of Colorectal Neoplasms, has completed, sponsored by Avantis Medical Systems.

COMPLETED
Registry status
NA
Development phase
328 participants
Enrollment target
9
Study locations

Study Summary

The Third Eye Retroscope is a device that can be used with a colonoscope to improve the ability of a physician to see areas of the colon that may be hidden from the view of the colonoscope. Previous studies have shown that physicians are able to detect additional polyps when they use the device along with the colonoscope. The purpose of this study is to determine whether physicians can detect greater numbers of additional polyps as they gain in experience with the device.

Primary Outcome

Adenomas detected with the colonoscope alone vs. with the Retroscope

Conditions Studied

Interventions

  • DEVICE Third Eye Retroscope

Study Locations (9)

Texas

  • Parkland Hospital - Dallas
  • Baylor University Medical Center - Dallas
  • S.W. Fort Worth Endoscopy Center - Fort Worth
  • North Hills Hospital - North Richland Hills

Illinois

  • University of Chicago - Chicago
  • NorthShore University HealthSystem - Evanston

Florida

  • Florida Hospital - Celebration

Massachusetts

  • University of Massachusetts - Worcester

Minnesota

  • Hennepin County Medical Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 328 participants
Start Date 2009-01
Est. Completion 2009-10
Phase NA
Avantis Medical Systems

2 total trials

What the finished NCT00969124 record still lists

NCT00969124 is an interventional study that assigns participants to a tested intervention. The registered 328 participants enrollment target is mid-sized for trials with a published cap, below the 570-participant average among 54 other Colorectal Neoplasms trials with a reported enrollment target (42% lower).

The record links to 1 condition, with Colorectal Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Third Eye Retroscope is the first listed.

NCT00969124 lists 9 locations in 5 states (Texas, Illinois, Florida).

Frequently Asked Questions

What is clinical trial NCT00969124 about?

NCT00969124 is a clinical study titled "Impact of Experience on Results With the Third Eye Retroscope". The Third Eye Retroscope is a device that can be used with a colonoscope to improve the ability of a physician to see areas of the colon that may be hidden from the view of the colonoscope. Previous studies have shown that physicians are able to detect additional polyps when they use the device alo...

What is the current status of trial NCT00969124?

This trial is currently completed. It is a NA study. The enrollment target is 328 participants. The study started on 2009-01. Estimated completion is 2009-10.

What conditions does trial NCT00969124 study?

This clinical trial studies the following conditions: Colorectal Neoplasms.

What interventions are being tested in trial NCT00969124?

The interventions under investigation include: Third Eye Retroscope (DEVICE).

Who is sponsoring clinical trial NCT00969124?

This trial is sponsored by Avantis Medical Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00969124 being conducted?

This trial has 9 study locations across Florida, Illinois, Massachusetts, Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00969124's enrollment target sits among peer trials

328 24th of 54 higher than 31 of 54 other Colorectal Neoplasms trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05156983 · 328 participants · Phase 3

    A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

  • NCT05380401 · 328 participants · NA

    Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

  • NCT05548413 · 328 participants · NA

    Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies

  • NCT06393725 · 328 participants · NA

    Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00969124, the US trial registry maintained by the National Library of Medicine. NCT00969124 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.